Arjun Gupta, Michelle Tregear, Makala B Pace, Rachel I Vogel
{"title":"Stick With Intravenous or Give Subcutaneous a Shot? Time and Other Considerations When Evaluating Cancer Drug Formulations.","authors":"Arjun Gupta, Michelle Tregear, Makala B Pace, Rachel I Vogel","doi":"10.1200/OP-24-00501","DOIUrl":null,"url":null,"abstract":"<p><p>Time and other considerations when evaluating a switch to newer drug formulations (eg, subQ vs IV).</p>","PeriodicalId":14612,"journal":{"name":"JCO oncology practice","volume":" ","pages":"267-269"},"PeriodicalIF":4.7000,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11787399/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"JCO oncology practice","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1200/OP-24-00501","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/8/2 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Time and other considerations when evaluating a switch to newer drug formulations (eg, subQ vs IV).
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
